Form 4: Hartford President Exercises, Sells HIG Stock
Insider Transaction Report
Hartford Insurance Group President Adin M. Tooker exercised and sold 8,307 shares of common stock, while also receiving a new grant of 28,982 stock options.
Summary
- Adin M. Tooker, President of Hartford Insurance Group, Inc. (HIG), reported transactions involving the company's common stock.
- On February 25, 2026, Mr. Tooker acquired 8,307 shares of common stock by exercising stock options at a price of $53.81 per share.
- Concurrently, Mr. Tooker disposed of 8,307 shares of common stock at a price of $140.54 per share.
- These transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on August 25, 2025.
- Following these transactions, Mr. Tooker beneficially owns 38,208.27 shares of common stock directly.
- Additionally, Mr. Tooker was granted 28,982 stock options on February 24, 2026, with an exercise price of $140.54, which will vest in three equal annual installments starting February 24, 2027.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, reflecting standard executive compensation practices and pre-planned stock transactions that do not inherently signal a change in company fundamentals or outlook.
Positives
- The new grant of 28,982 stock options to the President aligns executive incentives with long-term company performance.
- The executive realized value from previously granted stock options, demonstrating the effectiveness of the company's compensation structure.
Negatives
- The sale of 8,307 shares by a key executive, even if pre-planned, represents a reduction in direct insider ownership.
Future Outlook
The filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic direction, as it is solely an insider transaction report.
Industry Context
StockSavvy.ai notes that executive option exercises and subsequent share sales, particularly when conducted under a Rule 10b5-1 trading plan, are routine events in the financial industry. These transactions are typically part of an executive's long-term compensation strategy, allowing them to realize value from vested equity awards and manage personal finances, often including tax obligations.
Stakeholder Impact
- Minor impact on shareholders due to executive share sale, which is part of normal compensation practices.
- The new option grant aligns the President's interests with long-term shareholder value creation.
Next Steps
- Future vesting of the newly granted 28,982 stock options on February 24, 2027, February 24, 2028, and February 24, 2029.
Key Dates
| Date | Description |
|---|---|
| 08/25/2025 | Rule 10b5-1 trading plan adopted by Mr. Tooker. |
| 02/27/2021 | Stock options with an exercise price of $53.81 became fully exercisable. |
| 02/26/2022 | Stock options with an exercise price of $49.01 became fully exercisable. |
| 02/25/2023 | Stock options with an exercise price of $55.27 became fully exercisable. |
| 02/23/2024 | Stock options with an exercise price of $51.87 became fully exercisable. |
| 02/28/2024 | First third of stock options with an exercise price of $78.28 became exercisable. |
| 02/23/2025 | Stock options with an exercise price of $69.41 became fully exercisable. |
| 02/27/2025 | First third of stock options with an exercise price of $95.74 became exercisable. |
| 02/28/2025 | Additional one-third of stock options with an exercise price of $78.28 became exercisable. |
| 02/24/2026 | Earliest transaction date; new stock options with an exercise price of $140.54 were granted. |
| 02/25/2026 | Transaction date for the exercise of 8,307 stock options and subsequent sale of common stock. |
| 02/25/2026 | First third of stock options with an exercise price of $116.41 became exercisable. |
| 02/26/2026 | Form 4 filing date. |
| 02/27/2026 | Additional one-third of stock options with an exercise price of $95.74 will become exercisable. |
| 02/28/2026 | Remaining one-third of stock options with an exercise price of $78.28 will become exercisable. |
| 02/24/2027 | First third of stock options with an exercise price of $140.54 will become exercisable. |
| 02/25/2027 | Additional one-third of stock options with an exercise price of $116.41 will become exercisable. |
| 02/27/2027 | Remaining one-third of stock options with an exercise price of $95.74 will become exercisable. |
| 02/27/2028 | Expiration date for stock options with an exercise price of $53.81. |
| 02/24/2028 | Additional one-third of stock options with an exercise price of $140.54 will become exercisable. |
| 02/25/2028 | Remaining one-third of stock options with an exercise price of $116.41 will become exercisable. |
| 02/24/2029 | Remaining one-third of stock options with an exercise price of $140.54 will become exercisable. |
| 02/26/2029 | Expiration date for stock options with an exercise price of $49.01. |
| 02/25/2030 | Expiration date for stock options with an exercise price of $55.27. |
| 02/23/2031 | Expiration date for stock options with an exercise price of $51.87. |
| 02/23/2032 | Expiration date for stock options with an exercise price of $69.41. |
| 02/28/2033 | Expiration date for stock options with an exercise price of $78.28. |
| 02/27/2034 | Expiration date for stock options with an exercise price of $95.74. |
| 02/25/2035 | Expiration date for stock options with an exercise price of $116.41. |
| 02/24/2036 | Expiration date for stock options with an exercise price of $140.54. |
Recommendation
holdThe Form 4 details a routine executive stock option exercise and sale, executed under a Rule 10b5-1 plan, alongside a new option grant. These transactions are typical for executive compensation and do not indicate a change in the company's fundamental outlook or warrant a shift in investment strategy based solely on this filing.
Keywords
Hartford Insurance Group, HIG, Adin M. Tooker, Form 4, Insider Trading, Stock Options, Executive Compensation, Share Sale, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.